Outcomes of intratympanic gentamicin injection to treat Ménière's disease

Otology and Neurotology

Volumn 33, Issue 5, 2012, Pages 706-714

  Huon, Leh Kiong ^a   Fang, Te Yung ^a   Wang, Pa Chun ^a,b,c  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adult; Antibiotics; Ear; Evidence based medicine; Hearing loss; Vertigo

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN;

EARDRUM; HUMAN; MENIERE DISEASE; META ANALYSIS; REVIEW; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; GENTAMICINS; HUMANS; MENIERE DISEASE; TREATMENT OUTCOME; TYMPANIC MEMBRANE;

EID: 84862854161     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e318259b3b1     Document Type: Article

References (23)

1. Diamond C, O'Connell DA, Hornig JD, et al. Systematic review of intratympanic gentamicin in Meniere's disease. J Otolaryngol 2003;32:351-61.
2. Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Ménière's disease: A meta-analysis. Otol Neurotol 2004;25:544-52.
3. Cohen-Kerem R, Kisilevsky V, Einarson TR, et al. Intratympanic gentamicin for Menière's disease: A meta-analysis. Laryngoscope 2004;114:2085-91.
4. Pullens B, van Benthem PP. Intratympanic gentamicin for Ménière's disease or syndrome. Cochrane Database Syst Rev 2011;16:CD008234.
5. Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, et al. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin. Laryngoscope 2007; 117:1474-81.
6. Kaasinen S, Pyykkö I, Ishizaki H, Aalto H. Intratympanic gentamicin in Meniere's disease. Acta Otolaryngol 1998;118:294-8.
7. Lange G,Maurer J, Mann W. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease. Laryngoscope 2004;114:102-5.
8. Martin E, Perez N. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's disease. Otol Neurotol 2003; 24:800-6.
9. Minor LB. Intratympanic gentamicin for control of vertigo in Meniere's disease: Vestibular signs that specify completion of therapy. Am J Otol 1999;20:209-19.
10. Stokroos R,KingmaH. Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Ménière's disease: A prospective, double-blind, placebo-controlled, randomized clinical trial. Acta Otolaryngol 2004;124:172-5.
11. Wu IC, Minor LB. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Laryngoscope 2003;113:815-20.
12. American Academy of OtolaryngologyYHead and Neck Foundation, Inc. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. Otolaryngol Head Neck Surg 1995;113:181-5.
13. Casani A, Nuti D, Franceschini SS, et al. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: Effects on vestibular function. Otolaryngol Head Neck Surg 2005;133:929-35.
14. Horii A, Saika T, Uno A, et al. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease. Otol Neurotol 2006;27:896-900.
15. Helling K, Schönfeld U, Clarke AH. Treatment of Méniè re's disease by low-dosage intratympanic gentamicin application: Effect on otolith function. Laryngoscope 2007;117:2244-50.
16. Harner SG, Driscoll CL, Facer GW, et al. Long-term follow-up of transtympanic gentamicin for Ménière's syndrome. Otol Neurotol 2001;22:210-4.
17. Postema RJ, Kingma CM, Wit HP, et al. Intratympanic gentamicin therapy for control of vertigo in unilateral Menière's disease: A prospective, double-blind, randomized, placebo-controlled trial. Acta Otolaryngol 2008;128:876-80.
18. Quaranta A, Aloisi A, De Benedittis G, et al. Intratympanic therapy for Ménière's disease: High-concentration gentamicin with roundwindow protection. Ann N Y Acad Sci 1999;884:410-24.
19. Quaranta A, Scaringi A, Aloidi A, et al. Intratympanic therapy for Ménière's disease: Effect of administration of low concentration of gentamicin. Acta Otolaryngol 2001;121:387-92.
20. Honrubia V, Bell TS, Harris MR, Baloh RW, Fisher LM. Quantitative evaluation of dizziness characteristics and impact on quality of life. Am J Otol 1996;17:595-602.
21. Jacobson GP, Newman CW. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg 1990; 116:424-7.
22. Yardley L, Hallam RS. Psychosocial aspects of balance and gait disorders. In: Bronstein AM, Brandt T, Wollacott M, eds. Clinical Disorders of Balance, Posture and Gait. London, UK: Arnold; 1996;194-210.
23. Schuknecht HF. Ablation therapy in the management of Menière's disease. Acta Otolaryngol Suppl 1957;132:1-42.